Following Ruan Decision, DOJ Drops Controlled Substance Case

October 14, 2022 
Shortly after the U.S. Supreme Court’s recent decision in Ruan v. United States, which held that criminal liability under the Controlled Substances Act requires a prescriber of controlled substances to act knowingly or intentionally outside his or her usual professional practice, the Department of dropped criminal charges for the unlawful distribution of opioids in United States v. Rattini, et al. 1

House-Passed MOUD Bill Needs Senate Approval

November 11, 2022
S.3257 Would Ease Restriction on Injectable Buprenorphine.

Individual Stories Underlie Addiction

September 12, 2022
In this review of the Hulu series Dopesick, CUSP Senior Fellow Lynn R. Webster, M.D., and journalist Hazel Shahgholi discuss the show’s hype, inaccuracies, and perpetuations of stigma and stereotypes surrounding substance use disorders.

Statement on Supreme Court Decision in Ruan v. U.S.

June 27, 2022
Washington, DC – Today, the Center for U.S. Policy published a statement in response to the unanimous decision of the U.S. Supreme Court in Ruan v. U.S. In the statement, CUSP’s chairman explains why the ruling is good for patients as well as substance use disorder and drug poisoning prevention.

The Supreme Court Is About To Affect Every Prescriber in America

May 5, 2022

In this Journal of Opioid Management op-ed, Center for U.S. Policy Senior Fellow Lynn Webster, M.D., and co-authors explain that state licensing boards and civil lawsuits, along with the federal government’s administrative framework, are more appropriate forums than federal criminal courts when dealing with questions surrounding medical care.

New Resources Educate Decision Makers on Insurance Coverage of Rx Digital Therapies

March 28, 2022
Thirty-three not-for-profit organizations sent a letter to commend Members of Congress for introducing a bill to provide Medicare coverage and create a new Medicaid payment category for prescription digital therapies. The “Access to Prescription Digital Therapeutics Act of 2022” is sponsored by Sens. Jeanne Shaheen (NH) and Shelley Moore Capito (WV), and Reps. Mike Thompson (CA-5) and David McKinley (WV-01).

Federal Government Facilitates Access To Rx Digital Behavioral Therapies

March 23, 2022 

The Center for U.S. Policy, Aimed Alliance, and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. “We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health.”

Collaboration Should Be Lauded, Not Denounced

January 20, 2022

Center for U.S. Policy Senior Fellow Lynn Webster, M.D. sent the following letter in response to Jim Rendon’s article in The Chronicle of Philanthropy entitled “How Nonprofits Helped Fuel the Opioid Crisis.”

CUSP Files Amicus Brief in Ruan Supreme Court Case

January 7, 2022

CUSP, together with three other friends of the court, has filed an amicus brief asking the U.S. Supreme Court to end the federal government’s prosecutions of health care providers for unintentional prescribing errors. This case is “about the millions of people who need and use controlled medicines responsibly….”

Bill Would Ease Restrictions on OUD Treatment

November 18, 2021

A bill introduced in the U.S. House of Representatives would loosen federal restrictions on access to medication for opioid use disorder. The Improving Access to Care and Treatment (IMPACT) Act would increase the amount of time prescribers may store long-acting injectable (LAI) buprenorphine dispensed from a specialty pharmacy for administration to their patients.

ONDCP Announces Model Opioid Litigation Proceeds Act

October 21, 2021

Today, the Office of National Drug Control Policy (ONDCP) announced the release of a model law for state legislatures that would help ensure opioid litigation proceeds are directed to addressing substance use disorders and drug-related harms in impacted communities and with public accountability.

CUSP Appoints Dr. Lynn Webster as Senior Fellow

July 12, 2021

CUSP welcomes new senior fellow with focus on ensuring credible science, sound economics, and the rule of law underpin U.S. health and drug policy.

Drug Poisoning Crisis Involves Many Substances

December 20, 2021

Center for U.S. Policy Senior Fellow Lynn Webster, M.D. sent the following letter to Margaret Brennan in response to her CBS News “Face the Nation” segment on the “other” crisis in America.

Center for U.S. Policy Urges Federal Government Not To Take State Opioid Litigation Proceeds

December 9, 2021

This week, the not-for-profit Center for U.S. Policy (CUSP) is urging the federal government not to pursue any claims it may have to state opioid litigation proceeds. “U.S. communities desperately need more resources to prevent and treat substance use disorders, provide compassionate care for people who use drugs, and support people in recovery.”

Mississippi Law Violates Women’s Privacy, Autonomy

September 29, 2021

Mississippi’s ban on nearly all abortions after 15 weeks forces women to carry pregnancies to term under adverse circumstances and increases the risk of maternal mortality and other health problems, according to a public health  amicus brief filed in the United States Supreme Court on September 20.

Federal Drug Policy Requires Greater Economic Balance

May 19, 2021

CUSP’s chairman tells PAINWeek that the federal government can improve drug policy by better addressing both demand for and supply of controlled medications and illicit substances.

CUSP Names Executives ‘Qualified and Ready on Day One’

December 15, 2020

Nonprofit tells Biden-Harris Transition Team that no woman has ever served as drug czar and states, “It is time for a woman to hold that position.”

DEA Expanding Surveillance of Prescription Drug Data

November 11, 2020

CUSP’s chairman discusses the impact of the new RFP from the DEA that asks software contractors to create a nationwide data system that will increase the surveillance of prescriptions.

Feds Warn of Scammers Impersonating DEA Agents

August 5, 2020
The U.S. Drug Enforcement Administration (DEA) warns doctors, pharmacists, and the public about criminals posing as DEA agents and attempting to extort money from them. CUSP’s chairman cautions that the scammers have enough knowledge of the tactics DEA is employing against controlled-medication prescribers to be able to replicate them in other situations.

NC Medical Board Leaves Patients in Limbo

February 22, 2020

CUSP’s chairman discusses the fallout from a North Carolina prescriber being told to surrender his DEA registration.

Statement on U.S. Drug Overdose Death Data

January 30, 2020
The Center for U.S. Policy’s Christopher Piemonte, Policy Manager, issued the following statement today in response to data released by the Centers for Disease Control and Prevention (CDC) on U.S. drug overdose deaths.

Experts Side with DEA on Opioid Quota Issue

January 20, 2020
Policymakers have been calling for the Drug Enforcement Administration (DEA) to reduce the number of opioids produced each year. Policy Manager Christopher Piemonte writes that experts in policy, pain, and law enforcement are all aligned in their belief that this strategy will be ineffective and that to continue to suggest it indicates a lack of education on the part of the policymakers.

Big Business, Congress Focus on Drugs

December 12, 2019

CUSP’s chairman discusses a major U.S. retailer’s theory that a rise in thefts may be attributed to the drug abuse crisis. He also discusses the proposed drug pricing bill before Congress.

Stakeholders Ask Congress for Hearings on SUPPORT Act Implementation

December 7, 2019
CUSP is a part of nine organizations that submitted a joint letter to Congress calling for oversight hearings on the implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

Pain Doctor on DOJ Settlement: ‘It Was Extortion’

October 23, 2019

CUSP’s chairman discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”

Opioid Pharma Hatred Doing More Harm Than Good

October 13, 2019
CUSP’s chairman discusses anti-opioid sentiment and its impacts on patients with persistent pain. “Everyone is going to be anti-opioid these days—until they have a car crash that breaks their pelvis, or a loved one gets cancer.”

Lawyer Calls for DOJ To End ‘Indiscriminate Raids’ of Prescribers

July 25, 2019

In recent years, the DEA has been increasing the number of raids on prescribers. CUSP’s chairman gives more insight into this rising problem.

As CBD Sales Boom, Consumers Need Clarity

July 14, 2019

Based on the assorted promotional claims of cannabidiol (CBD) product marketers, it appears that the truth about CBD’s benefits and risks depends on whom you ask and when.

Treatment Instead of Jail Can Save Lives, Reduce Costs

May 9, 2019

CUSP’s chairman discusses the benefits of policies that direct people with mental health or substance use disorders who commit minor crimes into treatment, not jail.

FDA Must Change Course on Addiction Treatment Medications

April 25, 2019

CUSP’s chairman discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.

Three U.S. Crises Inextricably Linked

February 25, 2019

Three interconnected crises are currently happening in America: substance abuse, mental illness, and mass incarceration. All three can be curtailed by providing inmates with treatment and support during incarceration.

The Constitution, Compassion and Common Sense

December 20, 2018

Looking forward to the 2020 campaign cycle and beyond, the United States is facing three large national crises: substance abuse, mental illness, and mass incarceration. All of these can be addressed if we fulfill an obligation required of us not only by the Constitution, but also by compassion and common sense.

Ruling on Affordable Care Act ‘Deeply Flawed’

December 17, 2018

Michael Barnes discusses the judicial decision deeming the Affordable Care Act unconstitutional and the potential impacts on consumers and states.